BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. - Nesic K; Krais JJ; Wang Y; Vandenberg CJ; Patel P; Cai KQ; Kwan T; Lieschke E; Ho GY; Barker HE; Bedo J; Casadei S; et al. (Molecular cancer, 2024)